2009
DOI: 10.1186/1471-2105-10-s8-s7
|View full text |Cite
|
Sign up to set email alerts
|

MtSNPscore: a combined evidence approach for assessing cumulative impact of mitochondrial variations in disease

Abstract: Background: Human mitochondrial DNA (mtDNA) variations have been implicated in a broad spectrum of diseases. With over 3000 mtDNA variations reported across databases, establishing pathogenicity of variations in mtDNA is a major challenge. We have designed and developed a comprehensive weighted scoring system (MtSNPscore) for identification of mtDNA variations that can impact pathogenicity and would likely be associated with disease. The criteria for pathogenicity include information available in the literatur… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
19
0

Year Published

2011
2011
2020
2020

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 22 publications
(19 citation statements)
references
References 36 publications
0
19
0
Order By: Relevance
“…Disease mutations caused by defects in the mitochondrial proteins also show a similar pattern ( Fig. 4C; see also Bhardwaj et al 2009;Montoya et al 2009). Somatic cell mutations implicated as having a causal role in the pathogenesis of cancer (i.e., driver mutations) exhibit a trend similar to Mendelian disease variants ( Fig.…”
Section: Evolutionary Distributions Of Disease-associated Variantsmentioning
confidence: 56%
“…Disease mutations caused by defects in the mitochondrial proteins also show a similar pattern ( Fig. 4C; see also Bhardwaj et al 2009;Montoya et al 2009). Somatic cell mutations implicated as having a causal role in the pathogenesis of cancer (i.e., driver mutations) exhibit a trend similar to Mendelian disease variants ( Fig.…”
Section: Evolutionary Distributions Of Disease-associated Variantsmentioning
confidence: 56%
“…Driver mutations contribute to cancer progression and have a tendency to be found in many independent samples as compared to passenger mutations that, as the name suggests, hitchhike causing the cells with driver mutations to increase in number by the processes of natural selection and adaptation [39, 40, 88–90]. For mitochondrial DNA (mtDNA), four different tools (including PolyPhen and SIFT) have been combined along with the biochemical features and frequency of variants to evaluate mitochondrial nSNVs [91]. This approach was adopted because only 5% of disease-associated nSNVs in mtDNA were found to be harmful by all four in silico methods, even though each of these SNVs was predicted to be damaging by at least one method [91].…”
Section: Evolutionary Diagnosis Of Function-altering Mutations In Silicomentioning
confidence: 99%
“…For mitochondrial DNA (mtDNA), four different tools (including PolyPhen and SIFT) have been combined along with the biochemical features and frequency of variants to evaluate mitochondrial nSNVs [91]. This approach was adopted because only 5% of disease-associated nSNVs in mtDNA were found to be harmful by all four in silico methods, even though each of these SNVs was predicted to be damaging by at least one method [91]. …”
Section: Evolutionary Diagnosis Of Function-altering Mutations In Silicomentioning
confidence: 99%
“…LOVD is a commonly used tool for organizing locus-centric variation data. As of now, MitoLSDB has patient and variant information from 5231 individuals from 675 different populations [24], [28] from 27 different groups including patients with Alzheimer’s disease, Asthanozoospermic, Atypical psychosis, Breast cancer, Diabetes, Angiopathy, Deafness, Glioma, Parkinson’s disease, Teratozoospermic, Thyroid cancer, etc and can be accessed at http://mitolsdb.igib.res.in. MitoLSDB is a Locus-Specific DataBase (LSDB) for human mtDNA genes and provides access to standardized and annotated data compiled from different resources which are otherwise difficult to search and comprehend.…”
Section: Introductionmentioning
confidence: 99%